SILO PHARMA, INC. Additional Paid in Capital, Preferred Stock
SILO PHARMA, INC. (SILO) had Additional Paid in Capital, Preferred Stock of $17.53 million as of 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalPreferredStock · last filed 2024-03-25
- 2023-12-31: Additional Paid in Capital, Preferred Stock $17.53M.
- 2022-12-31: Additional Paid in Capital, Preferred Stock $17.51M.
| Period end | Additional Paid in Capital, Preferred Stock |
|---|---|
| 2023-12-31 | $17.53M 10-K · filed 2024-03-25 |
| 2022-12-31 | $17.51M 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |